台股 » 個股 » 神隆 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

神隆

(1789)
可現股當沖
  • 股價
    28.30
  • 漲跌
    ▲0.05
  • 漲幅
    +0.18%
  • 成交量
    604
  • 產業
    上市 生技醫療類股▲0.12%
  • 302人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
神隆 (1789)籌碼相關-台灣企銀-建成 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

台灣企銀-建成 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/06/1700.00229.2529.10-21,547-0.13%
2024/06/11229.1000.0029.2021,5380.13%
2024/05/2200.00229.2028.65-21,476-0.14%
2024/05/21229.5000.0029.3521,4530.14%
2024/04/03127.20127.4527.7509190.00%
2023/11/1700.00226.0325.90-2725-0.28%
2023/11/14125.7500.0025.7517630.13%
2023/09/2500.00427.1027.20-42,570-0.16%
2023/09/1200.00226.9526.80-22,968-0.07%
2023/09/0600.00227.0526.95-23,084-0.06%
2023/09/0500.00227.3527.25-23,085-0.06%
2023/08/18327.6300.0027.3033,0890.10%
2023/08/14128.0500.0028.0013,0660.03%
2023/08/11128.6000.0028.5513,0530.03%
2023/08/10528.9700.0029.0553,0390.16%
2023/08/0800.001631.2530.90-162,985-0.54%
2023/07/21231.8000.0031.5022,8010.07%
2023/07/18134.6000.0033.7012,2130.05%
2023/07/10528.85229.4529.5031,8490.16%
2023/07/06129.2000.0028.7011,7830.06%
2023/06/291029.7800.0029.50101,5840.63%
2023/06/20128.8000.0028.9011,4470.07%
2023/01/0600.00125.0525.05-11,790-0.06%
2022/11/2200.00124.4024.30-11,391-0.07%
2021/05/0300.00529.5029.55-51,719-0.29%
2021/04/27529.7000.0029.3051,5920.31%
2020/12/2800.00129.0028.85-11,017-0.10%
2020/09/09233.9000.0033.8026,8770.03%
2020/08/2500.00231.8531.85-27,867-0.03%
2020/08/0400.00532.5532.45-59,107-0.05%
2020/07/2100.00333.5033.45-310,183-0.03%
2020/07/2000.00532.4032.85-510,174-0.05%
2020/06/30638.3000.0037.7069,7170.06%
2020/06/22138.2000.0038.0019,1530.01%
2020/06/191038.8700.0039.15108,9050.11%
2020/06/1600.003035.5534.45-307,328-0.41%
2020/05/263033.3500.0032.25307,8370.38%
2020/05/0500.00132.2532.10-16,416-0.02%
2020/04/2400.00028.9028.8005,7390.00%
2020/04/07128.60128.1528.0004,9690.00%
2020/04/06828.874327.8529.40-354,874-0.72%
2020/03/313626.1900.0026.20364,6050.78%
2020/03/2300.0012.223.2023.20-12.24,306-0.28%
2020/03/12529.87931.3430.10-43,695-0.11%
2020/03/11133.60234.0332.30-13,440-0.03%
2020/03/101533.751034.0833.7553,2040.16%
2020/03/094336.694337.3637.5002,9530.00%
2020/03/06132.05131.8034.1002,3790.00%
2019/11/2500.00228.9328.65-21,293-0.15%
2019/11/21228.5000.0029.1021,0700.19%
2019/02/2500.00527.2027.40-5575-0.87%
2019/02/2200.00127.5527.40-1592-0.17%
2019/02/20127.6500.0027.7016720.15%
2019/02/19127.8500.0027.7516720.15%
2019/02/18127.6500.0027.8016690.15%
2019/02/15227.45127.9027.3016610.15%
2019/02/12127.1000.0027.1516550.15%
2019/01/24127.8000.0027.1516630.15%
2018/03/1900.000.133.0032.95-0.1906-0.01%
逸達前列腺癌新藥獲美藥證 神隆同步受惠Anue鉅亨-2021/05/27
〈神隆法說〉上游原物料漲幅過大 部分產品將啟動漲價Anue鉅亨-2021/05/26
〈神隆法說〉常熟廠代客研製新藥下半年放量 營運可望改善Anue鉅亨-2021/05/26
神隆 相關文章